BamSEC and AlphaSense Join Forces
Learn More

Cadence Pharmaceuticals Inc – Material Contracts

Formerly NASDAQ: CADX
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.33
from 10-K 36 pages Settlement Agreement
12/34/56
EX-10.2
from 8-K 2 pages Amended and Restated Cadence Pharmaceuticals, Inc. Director Compensation Policy Effective November 21, 2013
12/34/56
EX-10.1
from 8-K 4 pages Cadence Pharmaceuticals, Inc. Bonus Plan Effective January 1, 2014
12/34/56
EX-10.1
from 8-K 15 pages Third Amendment to Lease
12/34/56
EX-10.1
from 10-Q 2 pages Amended and Restated Cadence Pharmaceuticals, Inc. Director Compensation Policy Effective March 13, 2013
12/34/56
EX-10.3
from 10-Q 35 pages Manufacturing and Supply Agreement Dated as of March 4, 2013 by and Between Laboratorios Grifols, S.A. and Cadence Pharmaceuticals, Inc
12/34/56
EX-10.2
from 10-Q 13 pages Settlement and Termination Agreement
12/34/56
EX-10.31
from 10-K 24 pages License Agreement
12/34/56
EX-10.30
from 10-K 15 pages Settlement Agreement
12/34/56
EX-10.29
from 10-K 7 pages Waiver, Consent and Option Termination Agreement
12/34/56
EX-10.12
from 10-K 18 pages Cadence Pharmaceuticals, Inc. Executive Severance Plan
12/34/56
EX-10.11
from 10-K 4 pages Cadence Pharmaceuticals, Inc. Bonus Plan Effective January 1, 2013
12/34/56
EX-10.1
from 8-K 35 pages Amended and Restated Supply Agreement
12/34/56
EX-10.17
from 10-K 5 pages Second Amendment to Lease
12/34/56
EX-10.16
from 10-K 2 pages First Amendment to Lease
12/34/56
EX-10.11
from 10-K 4 pages Cadence Pharmaceuticals, Inc. Bonus Plan Effective January 1, 2012
12/34/56
EX-10.1
from 10-Q 2 pages Amended and Restated Cadence Pharmaceuticals, Inc. Director Compensation Policy Effective September 1, 2011
12/34/56
EX-10.1
from 10-Q 4 pages Cadence Pharmaceuticals, Inc. Amended and Restated Bonus Plan Effective January 1, 2011
12/34/56
EX-10.11
from 10-K 5 pages Cadence Pharmaceuticals, Inc. Bonus Plan Effective January 1, 2011
12/34/56
EX-10.1
from 8-K 59 pages Confidential Amended & Restated Development and Supply Agreement by and Between Cadence Pharmaceuticals, Inc. and Baxter Healthcare Corporation
12/34/56